Consolidated Portfolio Review Corp Pfizer Inc Transaction History

Consolidated Portfolio Review Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $59,132 - $76,806	-2,263 Reduced 17.1%	10,970 $316 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $14,344 - $16,766	-447 Reduced 3.27%	13,233 $439 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $20,660 - $23,903	572 Added 4.36%	13,680 $502 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $516,324 - $672,178	13,108 New	13,108 $535 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Consolidated Portfolio Review Corp, based on Form 13F filings with the SEC.

Stay updated on Consolidated Portfolio Review Corp with notifications on news.